Sec. 3. An insurer that issues an accident and sickness insurance policy may report to the drug utilization review board established by IC 12-15-35-19 the number of covered individuals who are: (1) less than eighteen (18) years of age; and (2) prescribed a stimulant medication approved by the federal Food and Drug Administration for the treatment of attention deficit disorder or attention deficit hyperactivity disorder. IC 27-8-31 Chapter 31. Interstate Insurance Product Regulation Compact 27-8-31-1 Purpose 27-8-31-2 Definitions 27-8-31-3 Interstate insurance product regulation commission 27-8-31-4 Commission powers 27-8-31-5 Commission members; action; bylaws 27-8-31-6 Management committee; legislative committee; liability 27-8-31-7 Commission action 27-8-31-8 Rules; uniform standards; opting out; judicial review 27-8-31-9 Commission information and records; disclosure; confidentiality; compacting state compliance and oversight 27-8-31-10 Dispute resolution 27-8-31-11 Product filing and approval 27-8-31-12 Disapproval; appeal; monitoring 27-8-31-13 Commission finances 27-8-31-14 Effectiveness of compact; amendments 27-8-31-15 Withdrawal of compacting state; reinstatement 27-8-31-16 Default of compacting state; reinstatement 27-8-31-17 Dissolution of compact 27-8-31-18 Severability 27-8-31-19 Effect on state law 27-8-31-20 Commission actions and agreements; effect on compacting states; constitutional violation
‹ Prev All Indiana sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.